# KERYX BIOPHARMACEUTICALS INC

KERYX BIOPHARMACEUTICALS INC is a company headquartered in Boston, MA, United States.

## Company overview

- **Legal name:** KERYX BIOPHARMACEUTICALS INC
- **Former names in filing history:** KERYX BIOPHAMAEUTICALS INC (2000-05-19 to 2000-06-30)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Boston, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001114220

## About

KERYX BIOPHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001114220, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-02-21, it reported annual revenue of USD 60,641,000; net income of USD -163,440,000; total assets of USD 158,872,000 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2017-12-31)

- **Revenue:** $60.6M (USD 60,641,000)
- **Net income:** -$163.4M (USD -163,440,000)
- **Total assets:** $158.9M (USD 158,872,000)
- **Cash and equivalents:** $93.5M (USD 93,526,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $32.0M (USD 31,983,000)
- **Net income:** -$161.1M (USD -161,095,000)
- **Total assets:** $141.4M (USD 141,427,000)
- **Cash and equivalents:** $111.8M (USD 111,810,000)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $13.7M (USD 13,680,000)
- **Net income:** -$123.1M (USD -123,145,000)
- **Total assets:** $258.7M (USD 258,685,000)
- **Cash and equivalents:** $200.3M (USD 200,290,000)

### FY2014 (period ended 2014-12-31)

- **Net income:** -$111.5M (USD -111,518,000)
- **Total assets:** $103.6M (USD 103,628,000)
- **Cash and equivalents:** $74.3M (USD 74,284,000)

## Recent SEC filings

- Form 8-K — filed 2018-12-13 — period 2018-12-11 — 8-K
- Form 10-Q — filed 2018-11-08 — period 2018-09-30 — 10-Q
- Form 8-K — filed 2018-11-08 — period 2018-11-08 — FORM 8-K
- Form 8-K — filed 2018-10-25 — period 2018-10-24 — FORM 8-K
- Form 8-K — filed 2018-10-01 — period 2018-10-01 — 8-K
- Form 10-Q — filed 2018-08-09 — period 2018-06-30 — 10-Q
- Form 8-K — filed 2018-08-08 — period 2018-08-08 — 8-K
- Form 8-K — filed 2018-07-20 — period 2018-07-18 — 8-K
- Form 8-K — filed 2018-07-03 — period 2018-06-29 — FORM 8-K
- Form 8-K — filed 2018-06-28 — period 2018-06-28 — 8-K
- Form 8-K — filed 2018-06-15 — period 2018-06-14 — FORM 8-K
- Form DEF 14A — filed 2018-05-31 — period 2018-06-29 — DEF 14A

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/keryx-biopharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology